• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE Back to Search Results
Device Problem Contamination (1120)
Patient Problems Abdominal Pain (1685); Peritonitis (2252)
Event Date 06/11/2014
Event Type  Injury  
Event Description
It was reported that a patient experienced a breach in aseptic technique during peritoneal dialysis (pd) therapy, which resulted in peritonitis manifested by abdominal pain and cloudy effluent.The patient was hospitalized on the same day as onset of the peritonitis.Treatment for the peritonitis was not reported.At the time of this report, it was unknown if the patient had recovered from the peritonitis.The patient was retrained on aseptic technique.Pd therapy was reported to be ongoing.Additional information was requested but is not available.
 
Manufacturer Narrative
(b)(4).Upon follow up, it was reported that initial treatment for the peritonitis consisted of intraperitoneal (ip) cefazolin (2g per day) and ip gentamycin (80 mg per day).Treatment with cefazolin and gentamycin were discontinued after two days and the patient was then treated with ip vancomycin (1g per day) and ip amikacin (300mg per day).The patient eventually recovered from the peritonitis and was discharged from the hospital.Should additional relevant information become available, a supplemental report will be submitted.
 
Manufacturer Narrative
(b)(4).Pt age: the patient was reported to have been born in 1967.This is a report of a use error, specifically a breach in aseptic technique, that resulted in peritonitis.Per baxter labeling, users are instructed to use aseptic technique when performing peritoneal dialysis therapy.A review of the label for the product family will be conducted.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
Manufacturer (Section G)
BAXTER HEALTHCARE CORPORATION
Manufacturer Contact
christina arnt
25212 w. illinois route 120
round lake, IL 60073
2242703198
MDR Report Key3927447
MDR Text Key4666948
Report Number1416980-2014-22087
Device Sequence Number1
Product Code KDJ
Combination Product (y/n)N
Reporter Country CodeVM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 06/16/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/09/2014
Initial Date FDA Received07/10/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received08/01/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
DIANEAL
Patient Outcome(s) Hospitalization; Required Intervention;
-
-